Date,Title,Source
"Wed, 03 Dec 2025 14:00:06 GMT",AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance,Yahoo Finance
"Wed, 03 Dec 2025 17:26:45 GMT","ABBV: Targeted deals, margin expansion, and innovation in IBD, dermatology, and neuroscience drive growth - TradingView",TradingView
"Tue, 02 Dec 2025 21:16:41 GMT","AbbVie (ABBV) Stock on December 2, 2025: Dividend Hike, Cancer Pipeline Momentum and 2026 Outlook - ts2.tech",ts2.tech
"Wed, 03 Dec 2025 21:16:32 GMT","XLV ETF Rises to $155.29 as LLY Stock, JNJ, and ABBV Drive Healthcare Sector Gains - TradingNEWS",TradingNEWS
"Tue, 02 Dec 2025 19:12:05 GMT",AbbVie (NYSE:ABBV) Is Increasing Its Dividend To $1.73 - simplywall.st,simplywall.st
"Sun, 30 Nov 2025 14:00:02 GMT",AbbVie (NYSE:ABBV) Will Pay A Larger Dividend Than Last Year At $1.73 - Yahoo Finance,Yahoo Finance
"Tue, 02 Dec 2025 15:47:00 GMT","Notable ETF Inflow Detected - XLV, JNJ, ABBV, MRK - Nasdaq",Nasdaq
"Tue, 02 Dec 2025 13:15:00 GMT","AbbVie (NYSE: ABBV) highlights ASH 2025 advances in T-cell engagers, BCL-2 and ADCs - Stock Titan",Stock Titan
"Mon, 01 Dec 2025 10:55:05 GMT",AbbVie: Increased Outlook For 2025 And Expansions Merit Continued 'Strong Buy' Rating - Seeking Alpha,Seeking Alpha
"Mon, 01 Dec 2025 22:06:06 GMT",AbbVie (ABBV) Faces New Generic Competition for Restasis - GuruFocus,GuruFocus
"Tue, 02 Dec 2025 19:30:12 GMT",Is AbbVie Stock Set for More Gains After 25% Rally and Product Launches? - simplywall.st,simplywall.st
"Mon, 01 Dec 2025 22:17:16 GMT","AbbVie (ABBV) Stock in December 2025: Atogepant Breakthrough, Q3 Beat and 2026 Outlook After Medicare Price Cuts - ts2.tech",ts2.tech
"Sun, 30 Nov 2025 20:38:17 GMT","AbbVie (ABBV) Stock Outlook Before the December 1, 2025 Open: Skyrizi’s Canada Win, Medicare Cuts and Fresh Analyst Targets - ts2.tech",ts2.tech
"Sat, 29 Nov 2025 08:12:31 GMT",Assessing AbbVie’s (ABBV) Valuation: Is There More Upside After Recent Performance? - Yahoo Finance,Yahoo Finance
"Sun, 30 Nov 2025 10:46:43 GMT","AbbVie Inc (ABBV) Stock on November 30, 2025: Analyst Downgrade, FDA Wins and Dividend Strength - ts2.tech",ts2.tech
"Sat, 29 Nov 2025 19:57:11 GMT","AbbVie (ABBV) Stock on November 29, 2025: Skyrizi’s Canada Win, Big-Money Flows and a Hot Valuation Debate - ts2.tech",ts2.tech
"Wed, 03 Dec 2025 01:10:00 GMT",Is It Too Late to Consider AbbVie After Its Strong Multi Year Share Price Rally? - Yahoo Finance UK,Yahoo Finance UK
"Mon, 01 Dec 2025 09:17:57 GMT",SKYRIZI® (risankizumab) Receives Positive Reimbursement Recommendation by Canada’s Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance - BioSpace,BioSpace
"Mon, 01 Dec 2025 11:38:48 GMT",AbbVie to Present Phase 3 ECLIPSE Data Demonstrating Atogepant (AQUIPTA®) Superiority Over Placebo in Achieving Pain Freedom for the Acute Treatment of Migraine at the 19th European Headache Congress - Adnkronos,Adnkronos
"Wed, 03 Dec 2025 07:18:12 GMT",AbbVie Inc. (NYSE:ABBV) Receives Average Rating of “Moderate Buy” from Analysts - Defense World,Defense World
"Tue, 02 Dec 2025 08:43:01 GMT",Beacon Pointe Advisors LLC Increases Stake in AbbVie Inc. $ABBV - Defense World,Defense World
"Sun, 30 Nov 2025 15:05:03 GMT",Wall Street Zen Downgrades AbbVie (NYSE:ABBV) to Buy - Defense World,Defense World
"Sat, 29 Nov 2025 08:27:34 GMT",Balanced Wealth Group LLC Raises Stock Holdings in AbbVie Inc. $ABBV - Defense World,Defense World
2025-12-03T17:53:28,AbbVie Inc. (ABBV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript,SeekingAlpha
2025-12-03T15:00:06,AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know,Yahoo
2025-12-03T02:10:46,Is It Too Late to Consider AbbVie After Its Strong Multi Year Share Price Rally?,Yahoo
2025-12-02T14:15:00,AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers,Yahoo
2025-12-01T14:01:06,"If You Invested $10K In AbbVie Stock 10 Years Ago, How Much Would You Have Now?",Yahoo
2025-12-01T06:55:05,"AbbVie: Increased Outlook For 2025 And Expansions Merit Continued ""Strong Buy"" Rating",SeekingAlpha
2025-11-30T15:00:02,AbbVie (NYSE:ABBV) Will Pay A Larger Dividend Than Last Year At $1.73,Yahoo
2025-11-29T09:12:31,Assessing AbbVie’s (ABBV) Valuation: Is There More Upside After Recent Performance?,Yahoo
